About VivoSense
VivoSense is a company based in San Diego (United States) founded in 2010 by Dudley Tabakin and Lance Myers.. VivoSense has raised $27.46 million across 6 funding rounds from investors including Debiopharm and Perceptive Advisors. VivoSense offers products and services including Wearable Sensor Services, Design and Configure, Data Collection and Cleaning, and Insight Delivery. VivoSense operates in a competitive market with competitors including Curebase, L7 Informatics, MDClone, Clinical Research IO and THREAD, among others.
- Headquarter San Diego, United States
- Founders Dudley Tabakin, Lance Myers
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$27.46 M (USD)
in 6 rounds
-
Latest Funding Round
$25 M (USD), Series A
Mar 04, 2022
-
Investors
Debiopharm
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of VivoSense
VivoSense offers a comprehensive portfolio of products and services, including Wearable Sensor Services, Design and Configure, Data Collection and Cleaning, and Insight Delivery. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
End-to-end implementation of wearable tech for clinical trials.
Tools for designing wearable sensor setups in research.
Services to generate and clean sensor data for trials.
Interpreting sensor data to deliver actionable insights.
Unlock access to complete
Software Development Team
4 people
Leadership Team
4 people
Project Team
1 people
Senior Team
1 people
Unlock access to complete
Funding Insights of VivoSense
VivoSense has successfully raised a total of $27.46M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $25 million completed in March 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series A — $25.0M
-
First Round
First Round
(07 Nov 2017)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2022 | Amount | Series A - VivoSense | Valuation | Debiopharm , Perceptive Advisors |
|
| Aug, 2020 | Amount | Series A - VivoSense | Valuation |
investors |
|
| May, 2019 | Amount | Series A - VivoSense | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in VivoSense
VivoSense has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Debiopharm and Perceptive Advisors. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Health-tech companies are targeted for venture capital investments.
|
Founded Year | Domain | Location | |
|
Biopharmaceutical company focused on oncology, infectious diseases, and orphan drugs
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by VivoSense
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - VivoSense
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Vivosense Comparisons
Competitors of VivoSense
VivoSense operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Curebase, L7 Informatics, MDClone, Clinical Research IO and THREAD, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Patient enrollment platform for decentralized clinical research is provided.
|
|
| domain | founded_year | HQ Location |
Clinical trial workflow management software is provided for laboratories.
|
|
| domain | founded_year | HQ Location |
Provider of software that creates synthetic medical records for fictitious patients
|
|
| domain | founded_year | HQ Location |
Clinical trial management software is provided for research sites.
|
|
| domain | founded_year | HQ Location |
Provider of patient research studies software
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Vivosense
Frequently Asked Questions about VivoSense
When was VivoSense founded?
VivoSense was founded in 2010 and raised its 1st funding round 7 years after it was founded.
Where is VivoSense located?
VivoSense is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Who is the current CEO of VivoSense?
Dudley Tabakin is the current CEO of VivoSense. They have also founded this company.
Is VivoSense a funded company?
VivoSense is a funded company, having raised a total of $27.46M across 6 funding rounds to date. The company's 1st funding round was a Series A of $2M, raised on Nov 07, 2017.
What does VivoSense do?
VivoSense was established in 2010 in San Diego, United States, within the health technology sector focused on clinical research. Wearable sensor solutions, data analysis services, and algorithm development are provided by Vivonoetics for trials involving data collection. The VivoSense platform supports analysis across disease states such as sleep disordered breathing, congestive heart failure, and cystic fibrosis. Over 500 pharmaceutical, research, and academic institutions have utilized these services globally.
Who are the top competitors of VivoSense?
VivoSense's top competitors include L7 Informatics, Curebase and Sonrai Analytics.
What products or services does VivoSense offer?
VivoSense offers Wearable Sensor Services, Design and Configure, Data Collection and Cleaning, and Insight Delivery.
Who are VivoSense's investors?
VivoSense has 2 investors. Key investors include Debiopharm, and Perceptive Advisors.